Literature DB >> 19913502

A mutation in the beta-myosin rod associated with hypertrophic cardiomyopathy has an unexpected molecular phenotype.

Thomas Z Armel1, Leslie A Leinwand.   

Abstract

Hypertrophic cardiomyopathy (HCM) is a common, autosomal dominant disorder primarily characterized by left ventricular hypertrophy and is the leading cause of sudden cardiac death in youth. HCM is caused by mutations in several sarcomeric proteins, with mutations in MYH7, encoding beta-MyHC, being the most common. While many mutations in the globular head region of the protein have been reported and studied, analysis of HCM-causing mutations in the beta-MyHC rod domain has not yet been reported. To address this question, we performed an array of biochemical and biophysical assays to determine how the HCM-causing E1356K mutation affects the structure, stability, and function of the beta-MyHC rod. Surprisingly, the E1356K mutation appears to thermodynamically destabilize the protein, rather than alter the charge profile know to be essential for muscle filament assembly. This thermodynamic instability appears to be responsible for the decreased ability of the protein to form filaments and may be responsible for the HCM phenotype seen in patients. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913502      PMCID: PMC2821741          DOI: 10.1016/j.bbrc.2009.11.062

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  New concepts in hypertrophic cardiomyopathies, part I.

Authors:  R Roberts; U Sigwart
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

2.  Using circular dichroism spectra to estimate protein secondary structure.

Authors:  Norma J Greenfield
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 3.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

4.  Mapping of a myosin-binding domain and a regulatory phosphorylation site in M-protein, a structural protein of the sarcomeric M band.

Authors:  W M Obermann; P F van der Ven; F Steiner; K Weber; D O Fürst
Journal:  Mol Biol Cell       Date:  1998-04       Impact factor: 4.138

5.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

Authors:  B J Maron; J M Gardin; J M Flack; S S Gidding; T T Kurosaki; D E Bild
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

6.  Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.

Authors:  Sara L Van Driest; Michele A Jaeger; Steve R Ommen; Melissa L Will; Bernard J Gersh; A Jamil Tajik; Michael J Ackerman
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

7.  Mutations at the same amino acid in myosin that cause either skeletal or cardiac myopathy have distinct molecular phenotypes.

Authors:  Thomas Z Armel; Leslie A Leinwand
Journal:  J Mol Cell Cardiol       Date:  2009-10-23       Impact factor: 5.000

8.  Mutations in the beta-myosin rod cause myosin storage myopathy via multiple mechanisms.

Authors:  Thomas Z Armel; Leslie A Leinwand
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-31       Impact factor: 11.205

Review 9.  Bioinformatics assessment of beta-myosin mutations reveals myosin's high sensitivity to mutations.

Authors:  Massimo Buvoli; Micah Hamady; Leslie A Leinwand; Rob Knight
Journal:  Trends Cardiovasc Med       Date:  2008-05       Impact factor: 6.677

10.  The C-terminal IgI domains of myosin-binding proteins C and H (MyBP-C and MyBP-H) are both necessary and sufficient for the intracellular crosslinking of sarcomeric myosin in transfected non-muscle cells.

Authors:  Robert E Welikson; Donald A Fischman
Journal:  J Cell Sci       Date:  2002-09-01       Impact factor: 5.285

View more
  6 in total

Review 1.  Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor.

Authors:  Jeffrey R Moore; Leslie Leinwand; David M Warshaw
Journal:  Circ Res       Date:  2012-07-20       Impact factor: 17.367

2.  Cardiomyopathy mutations in the tail of β-cardiac myosin modify the coiled-coil structure and affect integration into thick filaments in muscle sarcomeres in adult cardiomyocytes.

Authors:  Marcin Wolny; Melanie Colegrave; Lucy Colman; Ed White; Peter J Knight; Michelle Peckham
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

3.  Myosin storage myopathy mutations yield defective myosin filament assembly in vitro and disrupted myofibrillar structure and function in vivo.

Authors:  Meera C Viswanathan; Rick C Tham; William A Kronert; Floyd Sarsoza; Adriana S Trujillo; Anthony Cammarato; Sanford I Bernstein
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

4.  Myosin Storage Myopathy in C. elegans and Human Cultured Muscle Cells.

Authors:  Martin Dahl-Halvarsson; Malgorzata Pokrzywa; Manish Rauthan; Marc Pilon; Homa Tajsharghi
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

5.  A1603P and K1617del, Mutations in β-Cardiac Myosin Heavy Chain that Cause Laing Early-Onset Distal Myopathy, Affect Secondary Structure and Filament Formation In Vitro and In Vivo.

Authors:  Francine Parker; Matthew Batchelor; Marcin Wolny; Ruth Hughes; Peter J Knight; Michelle Peckham
Journal:  J Mol Biol       Date:  2018-04-14       Impact factor: 5.469

6.  Secondary Structure of the Novel Myosin Binding Domain WYR and Implications within Myosin Structure.

Authors:  Lynda M Menard; Neil B Wood; Jim O Vigoreaux
Journal:  Biology (Basel)       Date:  2021-06-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.